Tubular vs. Molded Glass Vial Alkaline Products Delamination Comparative Studies

Main Article Content

Anupam Chanda

Abstract

Tubular and molded glass vials are widely used as primary packaging materials for parenteral products, each offering distinct advantages and limitations in relation to chemical durability and delamination behavior. Tubular vials generally provide superior surface uniformity, dimensional accuracy, and overall chemical resistance, making them suitable for high-value and sensitive formulations. However, the high-temperature forming process can lead to localized compositional variations, increasing the risk of delamination at critical regions such as the base and shoulder.
In contrast, molded vials are produced through a single-step forming process that enables better redistribution of volatile components, resulting in improved structural homogeneity and reduced susceptibility to localized delamination. Despite this advantage, molded glass may exhibit comparatively lower hydrolytic resistance and can be more vulnerable to uniform surface corrosion when exposed to alkaline formulations.
Glass delamination is influenced by multiple factors, including formulation pH, buffer composition, glass chemistry, sterilization processes, and storage conditions. Alkaline products, particularly those containing phosphate or citrate buffers, significantly increase the risk of glass surface degradation. Preventive approaches such as surface treatments, appropriate glass selection, and the use of alternative materials like COC/COP or advanced coatings can mitigate these risks.
Overall, the selection between tubular and molded vials should be guided by product-specific requirements, balancing performance, stability, and cost considerations to ensure optimal container–product compatibility.

Article Details

Chanda, A. (2026). Tubular vs. Molded Glass Vial Alkaline Products Delamination Comparative Studies. Archives of Biotechnology and Biomedicine, 013–015. https://doi.org/10.29328/journal.abb.1001049
Short Communications

Copyright (c) 2026 Chanda A

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Jenke DR. Extractables and leachables considerations for prefilled syringes. PDA J Pharm Sci Technol. 2014;68(5):501–512.

Iacocca RG, Allgeier M. Corrosive attack of glass vials. Am Pharm Rev. 2007;10(6):82–89.

FDA. Guidance for Industry: Container Closure Systems for Packaging Human Drugs and Biologics. 2020.

Iacocca RG, Toltl NP. Glass delamination: a comparison of the inner surface of vials. PDA J Pharm Sci Technol. 2012;66(2):116–129.

Jenke DR, Castner J. Leachables from glass containers. J Pharm Sci. 2011;100(4):1270–1285.

Iacocca RG, Bostic J. Delamination of glass: causes and prevention. Pharm Technol. 2013;37(5):40–47.

Schaut RA, Weeks WJ. Chemical durability of glass containers. J Non Cryst Solids. 2011;357(10):195–201.

Gupta P. Advances in pharmaceutical packaging materials. Int J Pharm. 2019;567:118–130.

EMA. Guideline on Plastic Immediate Packaging Materials. 2019.

Iacocca RG. Surface chemistry of glass vials. J Mater Sci. 2010;45:102–110.

Ennis RD, Paskiet D. Stability considerations for parenteral packaging. PDA J Pharm Sci Technol. 2013;67(6):548–557.

Markovic I. Evaluation of polymer containers for biologics. Eur J Pharm Biopharm. 2020;154:123–130.